Community News

LOS ANGELES--(BUSINESS WIRE)--MedicalMaskSuperstore.com Brings a Full Selection of KN94 Premium Face Masks for the Retail Public and Corporate Clients

LANCASTER, Calif.--(BUSINESS WIRE)--MonolixSuite has been added to the Simulations Plus suite of software applications distributed in Japan by Northern Science Consulting.

LOS ANGELES--(BUSINESS WIRE)-- #calderamedical--Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. "Staying true to our commitment of being surgeon and patient focused, Caldera Medical collaborated with dozens of leading surgeons to bring enhanced ease of use and patient safety to life […]

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today confirmed that the Company’s RT-PCR test for SARS-CoV-2, the virus that causes COVID-19, can successfully detect the recently emerged Omicron variant of the virus. In addition, Fulgent is confident that its Next […]

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the establishment of an Innovation and Collaboration Center in Suzhou New District, China. Through this new center, experts will collaborate with customers to design upstream cell culture processes that meet their biomanufacturing needs. In the past decade,

IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the annual American Society of Hematology (ASH) meeting new data on the use of their proprietary machine learning approaches in the diagnosis of acute graft-versus-host disease (aGVHD) and for the stratifying of patients with diffuse large B-cell lymphoma (DLBCL) based on outcome after treatment with the standard R-CHOP. GTC will also present studies on their liquid biopsy and its rel

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals to Participate in Upcoming December 2021 Conferences

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus donates $25,000 to Dispensary of Hope, a national nonprofit devoted to delivering high-quality medication to underserved communities

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today issued a presentation on Centurion BioPharma Corporation's ("Centurion BioPharma") plans for a world-class cancer center in Las Vegas, Nevada. Centurion BioPharma is a private wholly-owned subsidiary that focuses on advancing the Company's proprietary, albumin […]

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that Raymond W. Cohen, chief executive officer of Axonics, has been awarded the 2021 Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council (SoCalBio). “This award recognizes bioscience and healthcare entrepreneurs and change-makers in the […]

LOS ANGELES--(BUSINESS WIRE)--The USPTO has extended the term of Puma Biotechnology's patent on NERLYNX (neratinib) for an additional 5 years, through Dec. 29, 2030.

ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare, which operates 45 hospitals in 14 states, ranked among the top 10 health systems in the nation for cost efficiency, according to the Lown Institute. Prime hospitals also ranked among the best with five hospitals among the top 20. The Lown Institute Hospitals Index is the first ranking to evaluate cost efficiency for more than 3,000 U.S. hospitals. The Cost Efficiency metric measures how well hospitals achieve excellent outcomes at a low cost t

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler 33rd Annual Healthcare Conference on Tuesday, November 30, 2021 at 2:00 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produce

IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease, completed enrollment in the TORUS 2 IDE clinical study (NCT04130737) in the United States. The study was designed to evaluate safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA and proximal […]

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals and GlaxoSmithKline sign exclusive license agreement for RNAi candidate ARO-HSD against NASH

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced today that it has released 28 Fungal Analyte Specific Reagents (ASRs) for use in molecular tests. (15 ASRs for mold pathogens, 10 ASRs for yeast pathogens, and 3 ASRs to detect dimorphic fungi). These ASR products utilize the company’s proprietary Barcoded Magnetic Bead (BMB) technology for specific detection of targeted organisms. For use as building blocks to develop and validate tests for the diagnosis of infectious […]

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will present data from the neratinib arm of the Phase II INSIGhT Trial at the 2021 Society for Neuro-Oncology Annual Meeting (SNO),

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference Presentation Available: Monday, November 22, 2021, 10:00 a.m. EST / 7:00 a.m. PST Evercore ISI 4th Annual HealthconX Conference Pre

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced the release of 9 abstracts that will be presented at the 2021 San Antonio Breast Cancer Symposium (SABCS), to be held at the Henry B. Gonzalez Convention Center in San Antonio, Texas, from December 7-10, 2021. Abstracts are available to the public online on the SABCS website at www.sabcs.org. Oral Presentation:       Abstract: GS4-10 Title: Neratinib + fulvestrant + trastuzumab for […]

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that Sharlene Evans, a proven leader, has joined the Company's Board of Directors replacing the retiring Dr. David Ralph.